Increased densities of nitric oxide synthase expressing neurons in the temporal cortex and the hypothalamic paraventricular nucleus of polytoxicomanic heroin overdose victims: Possible implications for heroin neurotoxicity

Acta Histochemica

Volumn 116, Issue 1, 2014, Pages 182-190

  Bernstein, Hans Gert ^a   Trübner, Kurt ^b   Krebs, Philipp ^a   Dobrowolny, Henrik ^a   Bielau, Hendrik ^a   Steiner, Johann ^a   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Heroin abuse; Immunohistochemistry; Morphometry; Neuronal nitric oxide synthase; Post mortem brain

Indexed keywords

DIAMORPHINE; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DECARBOXYLASE; NARCOTIC AGENT; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; CASE CONTROL STUDY; DRUG EFFECTS; DRUG OVERDOSE; ENZYMOLOGY; FEMALE; HEROIN DEPENDENCE; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; TEMPORAL LOBE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DRUG OVERDOSE; FEMALE; GLUTAMATE DECARBOXYLASE; GLUTAMATE-AMMONIA LIGASE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; NARCOTICS; NITRIC OXIDE SYNTHASE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; TEMPORAL LOBE;

EID: 84894905516     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.07.006     Document Type: Article

References (77)

1. Benavides-Piccione R., DeFelipe J. Different populations of tyrosine-hydroxylase-immunoreactive neurons defined by differential expression of nitric oxide synthase in the human temporal cortex. Cereb Cortex 2003, 13:297-307.
2. Bernstein H.G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998, 83:867-875.
3. Bernstein H.G., Baumann B., Danos P., Diekmann S., Bogerts B., Gundelfinger E.D., et al. Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 1999, 28:655-662.
4. Bernstein H.G., Jirikowski G.F., Heinemann A., Baumann B., Hornstein C., Danos P., et al. Low and infrequent expression of nitric oxide synthase/NADPH-diaphorase in neurons of the human supraoptic nucleus: a histochemical study. J Chem Neuroanat 2000, 20:177-183.
5. Bernstein H.G., Krell D., Braunewell K.H., Baumann B., Gundelfinger E.D., Diekmann S., et al. Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia. J Neurocytol 2001, 30:661-670.
6. Bernstein H.G., Bogerts B., Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 2005, 78:69-86.
7. Bernstein H.G., Krause S., Krell D., Dobrowolny H., Wolter M., et al. Strongly reduced number of parvalbumin-immunoreactive projection neurons in the mammillary bodies in schizophrenia: further evidence for limbic neuropathology. Ann N Y Acad Sci 2007, 1096:120-127.
8. Bernstein H.G., Sahin J., Smalla K.H., Gundelfinger E.D., Bogerts B., Kreutz M.R. A reduced number of cortical neurons show increased caldendrin protein levels in chronic schizophrenia. Schizophr Res 2007, 96:246-253.
9. Bernstein H.G., Ernst T., Lendeckel U., Bukowska A., Ansorge S., Stauch R., et al. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. J Psychiatr Res 2009, 43:1095-1105.
10. Bernstein H.G., Keilhoff G., Steiner J., Dobrowolny H., Bogerts B. Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy. CNS Neurol Disord Drug Targets 2011, 10:792-807.
11. Bernstein H.G., Dobrowolny H., Schott B.H., Gorny X., Becker V., Steiner J., et al. Increased density of AKAP5-expressing neurons in the anterior cingulate cortex of subjects with bipolar disorder. J Psychiatr Res 2013, 47:699-705.
12. Bernstein H.G., Tausch A., Wagner R., Steiner J., Seeleke P., Walter M., et al. Disruption of the glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase, CNS. Neurol Disord Drug Targets 2013, [in press].
13. Bielau H., Brisch R., Bernard-Mittelstaedt J., Dobrowolny H., Gos T., Baumann B., et al. Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder. Brain Res 2012, 1459:91-99.
14. Bhargava H.N., Cao Y.J. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse. Peptides 1997, 18:1629-1634.
15. Blanco E., Jirikowski G.F., Riesco J.M., Juanes J.A., Vázquez R. Coexistence of NADPH-diaphorase with tyrosine hydroxylase in hypothalamic magnocellular neurons of the rat. Neuropeptides 1997, 31:227-230.
16. Borsani E., Giovannozzi S., Boinsegna R., Rezzani R., Labanca M., Tschabitscher M., et al. Nitroxidergic system in human trigeminal ganglia neurons: a quantitative evaluation. Acta Histochem 2010, 112:444-451.
17. Büttner A., Mall G., Penning R., Weis S. The neuropathology of heroin abuse. Forensic Sci Int 2000, 113:435-442.
18. Carreira B.R., Carvalho C.M., Araújo I.M. Regulation of injury-induced neurogenesis by nitric oxide. Stem Cells Int 2012, [article number: 895659].
19. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
20. Costa A., Trainer P., Besser M., Grossman A. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 1993, 605:187-192.
21. Cuéllar B., Fernandez A.P., Lizasoain I., Moro M.A., Lorenzo P., Bentura J., et al. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology (Berl) 2000, 148:66-73.
22. Cunha-Oliveira T., Rego A.C., Garrido J., Borges F., Macedo T., Oliveira C.R. Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J Neurochem 2007, 101:543-554.
23. Daglish M.R., Williams T.M., Wilson S.J., Taylor L.G., Eap C.B., Augsburger M., et al. Brain dopamine response in human opioid addiction. Br J Psychiatry 2008, 193:65-72.
24. Deng X.S., Deitrich R.A. Ethanol metabolism and effects: nitric oxide and its interaction. Curr Clin Pharmacol 2007, 2:145-153.
25. D'Este L., Casini A., Pontieri F.E., Renda T.G. Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment. Brain Res 2006, 1083:151-158.
26. Dyuizen I., Lamash N.E. Histo- and immunocytochemical detection of inducible NOS and TNF-alpha in the locus coeruleus of human opiate addicts. J Chem Neuroanat 2009, 37:65-70.
27. Economidou D., Dalley J.W., Everitt B.J. Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking. Biol Psychiatry 2011, 69:266-274.
28. Egberongbe Y.I., Gentleman S.M., Falkai P., Bogerts B., Polak J.M., Roberts G.W. The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 1994, 59:561-578.
29. Eisch A.J., Barrot M., Schad C.A., Self D.W., Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci USA 2000, 97:7579-7584.
30. Erusalimsky J.D., Moncada S. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol 2007, 27:2524-2531.
31. Fernández-Cancio M., Fernández-Vtos E.M., Imperial S., Centelles J.J. Structural requirements of nezodiazepines for the inhibition of pig brain nitric oxide synthase. Brain Res Mol Brain Res 2001, 96:87-93.
32. Ferrini M., Wang C., Swerdloff R.S., Sinha-Hikim A.P., Rajfer J., Gonzales-Cadavid N.F. Aging-related increased expression of inducible nitric oxide synthase and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function. Neuroendocrinology 2001, 74:1-11.
33. Fricks-Gleason A.N., Keefe K.A. Evaluating the role of neuronal nitric oxide synthase-containing striatal interneurons in methamphetamine-induced dopamine neurotoxicity. Neurotox Res 2013, 24:288-292.
34. Gerber H., Borgwardt S.J., Schmid O., Gerhard U., Joechle W., Riecher-Rössler A., Wiesbeck G.A., Walter M. The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence. Eur Addict Res 2012, 18:116-123.
35. Glahn A., Heberlein A., Dürsteler-MacFarland K.M., Lenz B., Frieling H., Gröschl M., et al. Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients. Neuropsychobiology 2013, 67:111-115.
36. Itzhak Y., Ali S.F. Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs. Pharmacol Ther 2006, 109:246-262.
37. Jia S.W., Wang W., Liu Y., Wu Z.M. Neuroimaging studies of brain corpus striatum changes among heroin-dependent patients treated with herbal medicine, U'finer capsule. Addict Biol 2005, 10:293-297.
38. Kolesnikov Y.A., Pan Y.X., Babey A.M., Jain S., Wilson R., Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci USA 1997, 94:8220-8225.
39. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004, 27:739-749.
40. Kreek M.J., Levran O., Reed B., Schlussman S.D., Zhou Y., Butelman E.R. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 2012, 122:3387-3393.
41. Kuljis R.O., Shaphak P., Alcabes P., Roriguez de la Vega P., Fujimura R., Petito C.K. Increased density of neurons containing NADH diaphorase in the cerebral cortex of patients with HIV-1 infection and drug abuse. J Neuro-AIDS 2002, 2:19-35.
42. Lai B., Pu H., Cao Q., Jing H., Liu X. Activation of caspase-3 and c-Jun NH2-terminal kinase signaling pathways involving heroin-induced neuronal apoptosis. Neurosci Lett 2011, 502:209-213.
43. Lanier R.K., James S.G., Carrigan K.A., Carelli R.M., Lysle D.T. Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase. Drug Alcohol Depend 2002, 66:225-233.
44. Li C., Sinha R. Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev 2008, 32:581-596.
45. Li S.X., Shi J., Epstein D.H., Wang X., Zhang X.L., Bao Y.P., et al. Circadian alteration in neurobiology during 30 days of abstinence in heroin users. Biol Psychiatry 2009, 65:905-912.
46. Lüth H.J., Münch G., Arendt T. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 2002, 953:135-143.
47. Lysle D.T., How T. Heroin modulates the expression of inducible nitric oxide synthase. Immunopharmacology 2000, 46:181-192.
48. Mahadik S.P., Mukherjee S. Free radical pathology and antioxidant defence in schizophrenia: a review. Schizophr Res 1996, 19:1-17.
49. Melis M.R., Succu S., Mascia M.S., Sanna F., Melis T., Castelli M.P., et al. The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: involvement of paraventricular glutamic acid and nitric oxide. Neuropharmacology 2006, 50:219-228.
50. Monau T.R., Vargas V.E., Zhang L., Myers D.A., Ducsay C.A. Nitric oxide inhibits ACTH-induced cortisol production in near-term, long-term hypoxic ovine fetal adrenocortical cells. Reprod Sci 2010, 17:955-962.
51. Nath A., Hauser K.F., Wojna V., Booze R.M., Maragos W., Prendergast M., et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 2002, 31(Suppl. 2):S62-S269.
52. Özek M., Üresin Y., Güngör M. Comparison of the specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice. Life Sci 2003, 72:1943-1951.
53. Packer M.A., Stasiv Y., Benraiss A., Chmielnicki E., Grinberg A., Westphal H., et al. Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci USA 2003, 100:9566-9571.
54. Pearson J., Baden M.B., Richter R.W. Neuronal depletion in the globus pallidus of heroin addicts. Drug Alcohol Depend 1976, 1:349-356.
55. Qui Y.W., Jiang G.H., Su H.H., Lv X.F., Tian J.Z., Li L.M., et al. The impulsivity behaviour is correlated with prefrontal cortex gray matter volume reduction in heroin-dependent individuals. Neurosci Lett 2013, 538:43-48.
56. Ren X.H., Zhao J., Pu L., Ling K., Yin D.L., Pei G. Differential neurotoxicity of etorphine-like opiates: lack of correlation with their ability to activate opiate receptors. Toxicon 1998, 36:735-743.
57. Salach J.L., Singer T.P., Castagnoli N., Trevor A. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. Biochem Biophys Res Commun 1984, 125:831-835.
58. Sawynok J. The therapeutic use of heroin: a review of the pharmacological literature. Can J Physiol Pharmacol 1986, 64:1-6.
59. Schlaepfer T.E., Lancaster E., Heidbreder R., Strain E.C., Kosel M., Fisch H.U., et al. Decreased frontal white-matter volume in chronic substance abuse. Int J Neuropsychopharmacol 2006, 9:147-153.
60. Sunico C.R., Portillo F., González-Forero D., Moreno-López B. Nitric oxide-directed synaptic remodeling in the adult mammal CNS. J Neurosci 2005, 25:1448-1458.
61. Szczytkowski J.L., Lysle D.T. Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition. Psychopharmacology (Berl) 2007, 191:879-889.
62. Szczytkowski J.L., Lysle D.T. Dopamine D1 receptors within the basolateral amygdala mediate heroin-induced conditioned immunomodulation. J Neuroimmunol 2010, 226:38-47.
63. Tan M., Li Z., Ma S., Luo J., Xu S., Lu A., et al. Heroin activates Bim via c-Jun N-terminal kinase/c-Jun pathway to mediate neuronal apoptosis. Neuroscience 2013, 233:1-8.
64. Thompson C.M., Bernhard A.E., Strobel H.W. Barbiturate-induced expression of neuronal nitric oxide synthase in the rat cerebellum. Brain Res 1997, 754:142-146.
65. Tramullas M., Martínez-Cué C., Hurlé M.A. Chronic administration of heroin to mice produces up-regulation of brain apoptosis-related proteins and impairs spatial learning and memory. Neuropharmacology 2008, 54:640-652.
66. Urban N.B., Martinez D. Neurobiology of addiction: insight from neurochemical imaging. Psychiatr Clin N Am 2012, 35:521-541.
67. Voloboueva L.A., Giffard R.G. Inflammation, mitochondria, and the inhibition of adult neurogenesis. J Neurosci Res 2011, 89:1989-1996.
68. Wallace M.N., Tayebjee M.H., Rana F.S., Farquar D.A., Nyong A.O. Pyramidal neurons in pathological human motor cortex express nitric oxide synthase. Neurosci Lett 1996, 212:187-190.
69. Weber R.J., Gomez-Flores R., Smith J.E., Martin T.J. Neuronal adaptations, neuroendocrine and immune correlates of heroin self-administration. Brain Behav Immun 2009, 23:993-1002.
70. Wiklund N.P., Cellek S., Leone A.M., Iversen H.H., Gustafson L.E., Brundin L., et al. Visualisation of nitric oxide released by nerve stimulation. J Neurosci Res 1997, 47:224-232.
71. Wolters E.C., van Wijngaarden G.K., Stam F.C., Rengelink H., Lousberg R.J., Schipper M.E., et al. Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet 1982, 83:1233-1237.
72. Wu W., Zhu Y.S., Li S.B. Polymorphisms in the glutamate decarboxylase 1 gene associated with heroin dependence. Biochem Biophys Res Commun 2012, 422:91-96.
73. Yang M., Kavi V., Wang W., Wu Z., Hao W. The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects. Prog Neuropsychopharmacol Biol Psychiatry 2012, 36:282-289.
74. Yoo J.-H, Cho J.-H., Lee S.-Y, Lee S., Loh H.H., Ho I.K., et al. Differential effects of morphine-and cocaine-induced nNOS immunoreactivity in the dentate gyrus of hippocampus of mice lacking μ-opioid receptors. Neurosci Lett 2006, 395:98-102.
75. Zang M., Shen Q., Liu J. Effect of nitric oxide synthase inhibitor on signal transduction pathways of opitate tolerance in NG108-15 cells expressing iNOS gene. Zhonghua Yi Xue Za Zhi 1999, 79:764-768.
76. Zhang G.F., Ren Y.P., Sheng L.X., Chi Y., Duo W.J., Guo Z.N., et al. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence. Am J Drug Alcohol Abuse 2008, 34:760-768.
77. Zhang G.H., Wang B. Study of the changes of nNOS in chronic heroin dependence and spontaneous withdrawal in rats. Fa Yi Xue Za Zhi 2003, 19:68-71.